Annual SGA
$7.48 M
-$5.29 M-41.44%
December 31, 2023
Summary
- As of February 8, 2025, ITRM annual SGA is $7.48 million, with the most recent change of -$5.29 million (-41.44%) on December 31, 2023.
- During the last 3 years, ITRM annual SGA has fallen by -$3.58 million (-32.36%).
- ITRM annual SGA is now -45.92% below its all-time high of $13.82 million, reached on December 31, 2021.
Performance
ITRM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.78 M
-$121.00 K-6.37%
September 30, 2024
Summary
- As of February 8, 2025, ITRM quarterly SGA is $1.78 million, with the most recent change of -$121.00 thousand (-6.37%) on September 30, 2024.
- Over the past year, ITRM quarterly SGA has stayed the same.
- ITRM quarterly SGA is now -58.34% below its all-time high of $4.27 million, reached on June 30, 2021.
Performance
ITRM Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.88 B
-$30.55 M-1.65%
September 30, 2024
Summary
- As of February 8, 2025, ITRM TTM SGA is -$1.88 billion, with the most recent change of -$30.55 million (-1.65%) on September 30, 2024.
- Over the past year, ITRM TTM SGA has dropped by -$1.89 billion (-25021.67%).
- ITRM TTM SGA is now -3339.32% below its all-time high of -$54.74 million.
Performance
ITRM TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ITRM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.4% | 0.0% | -10000.0% |
| 3 y3 years | -32.4% | 0.0% | -10000.0% |
| 5 y5 years | -14.9% | 0.0% | -10000.0% |
ITRM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.9% | at low | -56.2% | +5.5% | -24.4% | at low |
| 5 y | 5-year | -45.9% | at low | -58.3% | +5.5% | -141.8% | at low |
| alltime | all time | -45.9% | +129.5% | -58.3% | +76.6% | -3339.3% | at low |
Iterum Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.78 M(-6.4%) | $7.55 M(-0.7%) |
| Jun 2024 | - | $1.90 M(-13.0%) | $7.61 M(+0.6%) |
| Mar 2024 | - | $2.19 M(+29.6%) | $7.56 M(+1.2%) |
| Dec 2023 | $7.48 M(-41.4%) | $1.69 M(-8.0%) | $7.48 M(-5.1%) |
| Sep 2023 | - | $1.83 M(-1.3%) | $7.88 M(-9.7%) |
| Jun 2023 | - | $1.86 M(-11.4%) | $8.72 M(-20.2%) |
| Mar 2023 | - | $2.10 M(+0.6%) | $10.93 M(-14.4%) |
| Dec 2022 | $12.77 M(-7.7%) | $2.09 M(-22.2%) | $12.77 M(-7.5%) |
| Sep 2022 | - | $2.68 M(-34.1%) | $13.81 M(-2.5%) |
| Jun 2022 | - | $4.07 M(+3.4%) | $14.15 M(-1.4%) |
| Mar 2022 | - | $3.93 M(+25.8%) | $14.36 M(+3.9%) |
| Dec 2021 | $13.82 M(+25.1%) | $3.13 M(+3.2%) | $13.82 M(+6.4%) |
| Sep 2021 | - | $3.03 M(-29.1%) | $12.99 M(+5.1%) |
| Jun 2021 | - | $4.27 M(+25.8%) | $12.36 M(+9.4%) |
| Mar 2021 | - | $3.40 M(+48.1%) | $11.30 M(+2.2%) |
| Dec 2020 | $11.05 M | $2.29 M(-4.4%) | $11.05 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $2.40 M(-25.3%) | $11.05 M(-4.6%) |
| Jun 2020 | - | $3.21 M(+1.9%) | $11.59 M(+2.4%) |
| Mar 2020 | - | $3.15 M(+37.2%) | $11.32 M(+0.3%) |
| Dec 2019 | $11.28 M(+28.5%) | $2.30 M(-21.7%) | $11.28 M(-3.6%) |
| Sep 2019 | - | $2.93 M(-0.2%) | $11.71 M(+2.4%) |
| Jun 2019 | - | $2.94 M(-5.7%) | $11.44 M(+10.1%) |
| Mar 2019 | - | $3.12 M(+14.4%) | $10.38 M(+18.2%) |
| Dec 2018 | $8.78 M(+96.7%) | $2.72 M(+2.5%) | $8.78 M(+19.1%) |
| Sep 2018 | - | $2.66 M(+40.9%) | $7.37 M(+28.5%) |
| Jun 2018 | - | $1.89 M(+24.5%) | $5.73 M(+15.3%) |
| Mar 2018 | - | $1.51 M(+15.5%) | $4.97 M(+11.4%) |
| Dec 2017 | $4.46 M(+37.0%) | $1.31 M(+28.5%) | $4.46 M(+41.6%) |
| Sep 2017 | - | $1.02 M(-9.1%) | $3.15 M(+47.9%) |
| Jun 2017 | - | $1.12 M(+11.4%) | $2.13 M(+111.4%) |
| Mar 2017 | - | $1.01 M | $1.01 M |
| Dec 2016 | $3.26 M | - | - |
FAQ
- What is Iterum Therapeutics annual SGA?
- What is the all time high annual SGA for Iterum Therapeutics?
- What is Iterum Therapeutics annual SGA year-on-year change?
- What is Iterum Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly SGA year-on-year change?
- What is Iterum Therapeutics TTM SGA?
- What is the all time high TTM SGA for Iterum Therapeutics?
- What is Iterum Therapeutics TTM SGA year-on-year change?
What is Iterum Therapeutics annual SGA?
The current annual SGA of ITRM is $7.48 M
What is the all time high annual SGA for Iterum Therapeutics?
Iterum Therapeutics all-time high annual SGA is $13.82 M
What is Iterum Therapeutics annual SGA year-on-year change?
Over the past year, ITRM annual SGA has changed by -$5.29 M (-41.44%)
What is Iterum Therapeutics quarterly SGA?
The current quarterly SGA of ITRM is $1.78 M
What is the all time high quarterly SGA for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly SGA is $4.27 M
What is Iterum Therapeutics quarterly SGA year-on-year change?
Over the past year, ITRM quarterly SGA has changed by $0.00 (0.00%)
What is Iterum Therapeutics TTM SGA?
The current TTM SGA of ITRM is -$1.88 B
What is the all time high TTM SGA for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM SGA is -$54.74 M
What is Iterum Therapeutics TTM SGA year-on-year change?
Over the past year, ITRM TTM SGA has changed by -$1.89 B (-25021.67%)